Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × Cyclosporine × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Myelodysplastic Syndromes 9 Lymphoma, Mantle-Cell 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia 5 Anemia, Refractory, with Excess of Blasts 5 Multiple Myeloma 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Follicular 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Hodgkin Disease 4 Myeloproliferative Disorders 3 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Prolymphocytic 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Biphenotypic, Acute 3 Burkitt Lymphoma 3 Blast Crisis 3 Waldenstrom Macroglobulinemia 2 Recurrence 2 Primary Myelofibrosis 2 Lymphoma, Large-Cell, Anaplastic 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Accelerated Phase 2 Hematologic Diseases 2 Graft vs Host Disease 2 Congenital Abnormalities 2

Interventions

Cyclophosphamide 11 Prednisone 8 Doxorubicin 8 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Vincristine 6 Azacitidine 5 fludarabine 4 Gemcitabine 4 Etoposide 4 Brentuximab Vedotin 4 romidepsin 3 belinostat 3 Dexamethasone 3 Biopsy 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 ruxolitinib 2 pembrolizumab 2 Lenalidomide 2 Bendamustine Hydrochloride 2 venetoclax 1 tislelizumab 1 tipifarnib 1 thymoglobulin 1 sodium-iodide symporter 1 selinexor 1 relatlimab 1 pomalidomide 1 ixazomib 1 ivarmacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡